's Information

Young-Hak Kim, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. AI for Revolutionizing Medical Auxiliary Diagnosis
  2. AI and Robotics for Cardiovascular Care
  3. Application of AI and Robotics for Cardiovascular Care
  4. Utilization of CT-Based Myocardial Segmentation
  5. CT-Based Myocardial Segmentation: Novel Method and Clinical Implication
  6. CT-Based Functional Imaging
  7. Invited Case Presentation & Focus Review: Left Main
  8. Lessons from CROSS and PERFECT Randomized Studies
  9. What Is Different for LM vs. with Non-LM Bifurcations
  10. No, What the Matter Is Not the Stenting Technique
  11. Key Messages of CROSS and PERFECT Trials: Prognostic Factors and Mechanisms
  12. CT-Perfusion
  13. Perfusion CT: One Stop Shop for Structure and Perfusion
  14. Access Complication and Bleeding
  15. [Noninvasive Tests Before Cath: Simple & Better] CT Myocardial Perfusion Imaging: One-Stop Shop for Structure & Function
  16. [Debates: SYNTAX, Clinical SYNTAX, and SYNTAX 2... Is It Mandatory Before LM Revascularization?] No, I Do Not Have Time.
  17. CROSS and PERFECT Trials: Impact of Kissing Balloon (vs. No Kiss) and 2-Stent (vs. 1-stent) Technique for Bifurcations
  18. Outcomes of PCI vs. CABG: Current and Future
  19. Key Lessons from CROSS and PERFECT Trial
  20. CT-Perfusion
  21. Qualitative and Quantitative Angiographic Evaluation of Bifurcation Lesion
  22. Outcomes of Second-generation DES for LM
  23. Perfusion CT
  24. Taped Lives: Implantation of CoreValve, Transfemoral
  25. Still Unsolved Issue: Bifurcation Lesion
  26. Outcome Mapping: Techniques, Devices & Skills
  27. Meta-analysis: PCI vs. CABG for Unprotected LM Stenosis
  28. When Should We Consider TAVI Procedure in Korea (Interventionist's Viewpoint)?
  29. Current Status of CROSS and PERFECT Study
  30. Second-generation DES for LM: PRECOMBAT-2
  31. Ischemia-guided Revascularization for Stable Angina Patients
  32. Ischemia-guided Optimal Revascularization
  33. Angiographic Limitation in LM and Bifurcation Interpretation
  34. [Debate: Incomplete/Complete and Functional/Anatomical Revascularization] Incomplete Revascularization Is Enough.
  35. Inability of AV Cross
  36. The Use of Nobori in Bifurcation
  37. K Xience Registry Results
  38. Periprocedural Patient management
  39. Impact of Complete Revascularization Strategy
  40. How to Improve Outcomes: Prognostics Factors of Bifurcation Stenting
  41. Current Challenges in Left Main Disease
  42. Guidelines and Current Practice in the Management of ACS Patients
  43. Anatomical and Functional Approach for Bifurcation PCI: Lessons from CROSS and PERFECT Trial
  44. Responsibilities of Investigators in Clinical Trials: From Consent to Safety Reporting
  45. New Bifurcation Trials of CROSS and PERFECT Trial Based on Functional and Anatomical Evaluation
  46. Can High Risk of LM Revascularization Be Identified with Preoperational Clinical and Angiographic Characteristics?: LM-SCORE
  47. Fundamental and QCA Measurement
  48. Angiographic Features of Bifurcation Coronary Lesions
  49. Risk Stratification of Left Main Revascularization
  50. DES for Complex Left Main: Experience in Columbia University
Conference Slides
Category